About 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one
5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one (PubChem CID 146447314) has the molecular formula C30H34N4O3
and a molecular weight of 498.63 g/mol. Its IUPAC name is 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one.
Molecular Properties
| Compound Name | 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one |
| PubChem CID | 146447314 |
| Molecular Formula | C30H34N4O3 |
| Molecular Weight | 498.63 g/mol |
| Exact Mass | 498.26 |
| IUPAC Name | 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one |
| SMILES | COC1CN(Cc2ccc(C#Cc3ccc(C(CNC4(C)CC4)Cc4nc[nH]c(=O)c4O)cc3)cc2)C1 |
| InChI | InChI=1S/C30H34N4O3/c1-30(13-14-30)33-16-25(15-27-28(35)29(36)32-20-31-27)24-11-9-22(10-12-24)4-3-21-5-7-23(8-6-21)17-34-18-26(19-34)37-2/h5-12,20,25-26,33,35H,13-19H2,1-2H3,(H,31,32,36) |
| InChIKey | YDUHSPAJVGGRLE-UHFFFAOYSA-N |
| XLogP | 3.17 |
| TPSA | 90.48 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 498.63 |
| LogP ≤ 5 | 3.17 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Analyze 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one?
The IUPAC name of 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one (CID 146447314) is 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one.
What is the SMILES notation for 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one?
The canonical SMILES for 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one is COC1CN(Cc2ccc(C#Cc3ccc(C(CNC4(C)CC4)Cc4nc[nH]c(=O)c4O)cc3)cc2)C1.
What is the InChIKey of 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one?
The InChIKey is YDUHSPAJVGGRLE-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H34N4O3/c1-30(13-14-30)33-16-25(15-27-28(35)29(36)32-20-31-27)24-11-9-22(10-12-24)4-3-21-5-7-23(8-6-21)17-34-18-26(19-34)37-2/h5-12,20,25-26,33,35H,13-19H2,1-2H3,(H,31,32,36).
What are the key properties of 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one?
5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one has a molecular weight of 498.63 g/mol, XLogP of 3.17, 9 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 5-hydroxy-4-[2-[4-[2-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]ethynyl]phenyl]-3-[(1-methylcyclopropyl)amino]propyl]-1H-pyrimidin-6-one is sourced from PubChem (CID 146447314), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).